Celldex Therapeutics, Inc

(NASDAQ:CLDX)

Latest On Celldex Therapeutics, Inc (CLDX):

Date/Time Type Description Signal Details
2023-05-18 18:33 ESTNewsCelldex Therapeutics: Revolutionizing Cancer Care With Innovative ImmunotherapiesN/A
2023-05-04 23:29 ESTNewsCelldex GAAP EPS of -$0.62, revenue of $1MN/A
2023-03-02 14:39 ESTNewsCelldex Therapeutics (CLDX) Presents At AAAAI ConferenceN/A
2023-02-28 18:15 ESTNewsCelldex GAAP EPS of -$0.56 beats by $0.03, revenue of $1.61M beats by $1.35MN/A
2023-02-27 12:59 ESTNewsCelldex gains 12% on Phase 1 data for urticaria candidateN/A
2023-02-20 07:02 ESTNewsCelldex: Long List Of Failures, High Valuation, But Good Data RecentlyN/A
2022-12-02 20:42 ESTNewsCelldex: Shares Continue To Rally On Barzolvolimab Hope (Technical Analysis)N/A
2022-11-09 22:05 ESTNewsCelldex GAAP EPS of -$0.57 beats by $0.01, revenue of $0.41M beats by $0.05MN/A
2022-08-09 00:09 ESTNewsCelldex Non-GAAP EPS of -$0.59 misses by $0.17, revenue of $0.16M misses by $0.24MN/A
2022-07-22 13:36 ESTNewsCelldex begins dosing in mid-stage study of barzolvolimab for skin disorderN/A
2022-07-14 20:11 ESTNewsCelldex: Barzolvolimab Plus Bispecific Antibodies AdvancementN/A
2022-07-01 20:44 ESTNewsCelldex posts early-stage data to support dose-dependent effect of urticaria therapyN/A
2022-05-06 00:47 ESTNewsCelldex GAAP EPS of -$0.49 misses by $0.04, revenue of $0.17M misses by $0.39MN/A
2022-03-01 04:31 ESTNewsCelldex GAAP EPS of -$0.43 misses by $0.02, revenue of $0.33M misses by $0.84MN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. (CLDX) CEO Anthony Marucci on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 04:31 ESTNewsCelldex Therapeutics, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-28 08:33 ESTNewsCelldex Q4 2021 Earnings PreviewN/A
2022-02-17 13:49 ESTNewsCelldex Therapeutics (CLDX) Investor Presentation - SlideshowN/A
2022-02-01 06:48 ESTNewsCelldex: Pipeline Of Drug Candidates Is Worth A LookN/A
2021-11-12 18:41 ESTNewsCelldex posts preclinical data from CDX-585 PD-1/ILT4 bispecific antibody programN/A
2021-11-10 04:54 ESTNewsCelldex EPS misses by $0.09, misses on revenueN/A
2021-09-29 12:19 ESTNewsCelldex's CDX-0159 improves quality of life and reduced disease impact in urticaria patientsN/A
2021-09-24 01:18 ESTNewsCelldex Therapeutics: A Best Price-Positioned Biotech Stock As Seen By Market-MakersN/A
2021-08-06 00:09 ESTNewsCelldex EPS beats by $0.06, beats on revenueN/A
2021-07-22 20:52 ESTNewsCelldex rises with bullish call from Guggenheim; potential of lead asset citedN/A
2021-07-21 00:15 ESTNewsCelldex: Powerful Medicines To Yield Further UpsidesN/A
2021-07-21 00:14 ESTNewsCelldex gains over a third on early-stage data for CDX-0159 in skin conditionN/A
2021-07-21 00:13 ESTNewsAnimal health ratings change at Guggenheim; Celldex up with positive views on trial data - today’s analyst actionN/A
2021-07-21 00:13 ESTNewsTempest Therapeutics, Xtant Medical leads healthcare gainers; Sigilon Therapeutics, TransMedics among major losersN/A
2021-07-21 00:12 ESTNewsCelldex Therapeutics proposes $175M capital raiseN/A
2021-07-21 00:12 ESTNewsCelldex's Latest Data For Chronic Inducible Urticaria Drug Is Only The BeginningN/A
2021-07-21 00:10 ESTNewsCelldex Therapeutics raises $250M via equity offeringN/A
2021-05-07 05:42 ESTNewsCelldex EPS misses by $0.08, misses on revenueN/A
2021-03-30 03:43 ESTNewsCelldex EPS misses by $0.18, beats on revenueN/A
2021-03-29 08:13 ESTNewsCelldex reports 80% complete response rate in CDX-0159 study in skin allergyN/A
2021-03-02 07:24 ESTAnalyst RatingThe Analyst Target Price has increased from $30.67 to $34.33.Buy
2021-02-24 03:23 ESTAnalyst RatingThe Analyst Target Price has increased from $26.33 to $30.67.Buy
2021-02-22 18:38 ESTNewsCelldex to expand development of CDX-0159 into prurigo nodularisN/A
2021-01-17 17:51 ESTNewsCelldex: New Monoclonal Therapeutic Line, 1Q21's CDX-0159's Initial Trial Data, And MoreN/A
2020-12-13 03:34 ESTFinancialsCompany financials have been released.Neutral
2020-12-09 15:50 ESTNewsDosing underway in Celldex's CDX-0159 study in skin allergyN/A
2020-11-19 19:29 ESTAnalyst RatingThe Analyst Target Price has increased from $23.5 to $26.33.Buy
2020-11-10 03:27 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 03:34 ESTAnalyst RatingThe Analyst Target Price has increased from $21.5 to $23.5.Buy
2020-11-07 15:24 ESTFinancialsCompany financials have been released.Neutral
2020-11-06 19:23 ESTEarnings EstimateAn EPS average of -$0.38 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-06 04:46 ESTNewsCelldex EPS in-line, beats on revenueN/A
2020-11-01 17:32 ESTFinancialsCompany financials have been released.Neutral
2020-10-30 12:32 ESTAnalyst RatingThe Analyst Target Price has increased from $17 to $21.5.Buy
2020-10-14 09:13 ESTNewsDosing underway in Celldex Therapeutics' CDX-0159 early-stage skin disorder studyN/A

About Celldex Therapeutics, Inc (CLDX):

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, which is being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in metastatic solid tumors and B cell lymphomas; CDX-3379, a monoclonal antibody designed to block the activity of ErbB3 that is in an early Phase II study in advanced head and neck squamous cell cancer in combination with Erbitux; CDX-0159, a Phase I monoclonal antibody that binds the KIT receptor and inhibits its activity; and CDX-527, a bispecific antibody that uses anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway. The company also holds exclusive rights to CDX-301 and CD40 ligand, which are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. Celldex Therapeutics, Inc. has research collaboration and license agreements with University of Southampton; Amgen Inc.; Yale University; and MedImmune, LLC. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.

CLDX Quotes by TradingView

See Advanced Chart

General

  • Name Celldex Therapeutics, Inc
  • Symbol CLDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 127
  • Last Split Factor1:15
  • Last Split Date2019-02-11
  • Fiscal Year EndDecember
  • IPO Date2008-03-10
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.celldex.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 133.88
  • Price/Book (Most Recent Quarter) 4.37
  • Enterprise Value Revenue 186.73
  • Enterprise Value EBITDA 0.01
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.38
  • Operating Margin -1150%
  • Return on Assets -17%
  • Return on Equity -29%
  • Revenue 4.52 million
  • Earnings Per Share -$3.74
  • Revenue Per Share $0.19
  • Gross Profit -39099000
  • Quarterly Earnings Growth 22.3%
View More

Highlights

  • Market Capitalization 988.78 million
  • EBITDA -51311000
  • PE Ratio -18.24
  • Analyst Target Price $34.33
  • Book Value Per Share $5.81
View More

Share Statistics

  • Shares Outstanding 39.57 million
  • Shares Float 28.85 million
  • % Held by Insiders 16%
  • % Held by Institutions 82.07%
  • Shares Short 2.87 million
  • Shares Short Prior Month 3.44 million
  • Short Ratio 4.18
  • Short % of Float 7%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 2.73
  • 52 Week High $30.17
  • 52 Week Low $1.51
  • 50 Day Moving Average 25.2
  • 200 Day Moving Average 18.9
View More

Dividends

  • Dividend Date 2019-02-11
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Celldex Therapeutics, Inc (CLDX) Dividend Calendar:

CLDX's last dividend payment was made to shareholders on February 11, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Celldex Therapeutics, Inc (CLDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$668000-$0.36-$0.360%
2020-06-302020-08-06$N/A-$0.50-$0.5813.79%
2020-03-312020-05-06$2.73 million-$0.73-$0.70-4.29%
2019-12-312020-03-26$887000-$0.64-$0.9331.18%
2019-09-302019-11-12$546000-$0.75-$0.8410.71%
2019-06-302019-08-07$715000-$0.84-$1.1728.21%
2019-03-312019-05-07$1.43 million-$1.40-$1.14-22.81%
2018-12-312019-03-07$1.76 million-$0.81-$1.2032.5%
2018-09-302018-11-07$941000-$0.60-$2.2573.33%
2018-06-302018-08-08$2.76 million-$1.65-$2.5535.29%
2018-03-312018-05-10$4.07 million-$12.60-$3.03-315.84%
2017-12-312018-03-07$3.46 million-$0.45-$3.7387.92%
2017-09-302017-11-07$3.92 million-$3.00-$3.9824.53%
2017-06-302017-08-08$3.83 million-$3.45-$4.0915.71%
2017-03-312017-05-09$1.53 million-$4.20-$4.281.75%
2016-12-312017-03-14$1.87 million-$4.50-$5.0510.89%
2016-09-302016-11-07$2.22 million-$4.35-$4.9712.42%
2016-06-302016-08-08$1.39 million-$4.80-$5.054.95%
2016-03-312016-05-05$1.3 million-$5.25-$5.24-0.29%
2015-12-312016-02-23$1.79 million-$4.95-$5.204.81%
2015-09-302015-11-05$1.03 million-$0.32-$0.358.57%
2015-06-302015-08-10$2.18 million-$0.33-$0.342.94%
2015-03-312015-04-29$486000-$0.33-$0.368.33%
2014-12-312015-02-24$1.48 million-$0.36-$0.35-2.86%
2014-09-302014-11-05$1.1 million-$0.31-$0.336.06%
2014-06-302014-08-06$592000-$4.80-$4.840.83%
2014-03-312014-05-01$416000-$4.95-$3.94-25.63%
2013-12-312014-03-03$620000-$4.05-$4.183.11%
2013-09-302013-11-08$980000-$4.35-$3.66-18.85%
2013-06-302013-08-06$97000-$3.60-$3.34-7.78%
2013-03-312013-05-02$2.41 million-$3.45-$3.30-4.55%
2012-12-312013-03-07$3.65 million-$4.05-$3.75-8%
2012-09-302012-11-01$3.11 million-$3.75-$3.62-3.59%
2012-06-302012-08-10$2.01 million-$3.45-$3.798.97%
2012-03-312012-05-03$2.43 million-$4.05-$3.57-13.45%
2011-12-312012-03-07$2.43 million-$4.35-$4.17-4.32%
2011-09-302011-11-02$2.36 million-$4.05-$3.84-5.47%
2011-06-302011-08-03$1.95 million-$4.05-$4.295.59%
2011-03-312011-05-04$2.52 million-$4.65-$4.54-2.42%
2010-12-312011-03-03$2.13 million-$3.60$3.15-214.29%
2010-09-302010-11-02$2.41 million-$4.35-$4.8710.68%
2010-06-302010-08-04$2.95 million-$4.50-$3.95-13.92%
2010-03-312010-05-04$3.71 million-$3.15-$3.9520.25%
2009-12-312010-03-04$4.73 million-$6.45-$4.30-50%
2009-09-302009-11-04$4.03 million-$6.75-$8.3218.87%
2009-06-302009-08-05$2.69 million-$8.25-$7.10-16.2%
2009-03-312009-05-05$3.73 million-$7.35-$6.90-6.52%
2008-12-312009-02-27$2.99 million-$7.05-$8.1012.96%
2008-09-302008-11-05$2.36 million-$7.50-$7.20-4.17%
2008-06-302008-08-06$1.96 million-$10.05-$8.40-19.64%
2008-03-312008-05-19$147000-$32.85-$9.97-229.49%
2007-12-312008-02-27$384000-$26.19
2007-09-302007-10-31$269000-$12.60-$12.600%
2007-06-302007-08-02$609000-$12.60-$18.0030%
2007-03-312007-05-03$144000-$87.35
2006-12-312007-03-07$255000-$14.40-$14.400%
2006-09-302006-11-01$199000-$14.40-$12.60-14.29%
2006-06-302006-08-02$317000-$14.40-$12.60-14.29%
2006-03-312006-05-09$128000-$7.20-$5.40-33.33%
2005-12-312006-03-08$36000-$9.00-$10.8016.67%
2005-09-302005-10-27$23000-$10.80-$12.6014.29%
2005-06-302005-08-03$12000-$10.80-$6.30-71.43%
2005-03-312005-05-05$N/A-$12.60-$11.70-7.69%
2004-12-312005-03-02-$9.00-$10.8016.67%
2004-09-302004-10-20-$8.98
2004-06-302004-07-22-$9.00-$9.000%
2004-03-312004-04-21-$5.40-$9.0040%
2003-12-312004-02-24-$9.00-$9.000%
2003-09-302003-10-22-$5.40-$10.8050%
2003-06-302003-07-23-$9.48
2003-03-312003-04-30-$10.01
2002-12-312003-02-26-$10.80-$12.6014.29%
2002-09-302002-10-23-$1.80-$16.2088.89%
2002-06-302002-07-24-$16.20-$17.105.26%
2002-03-312002-04-24-$14.40-$18.0020%
2001-12-312002-02-26-$19.80-$20.402.94%
2001-09-302001-10-25-$19.80-$23.4015.38%
2001-06-302001-08-02-$18.00-$22.8021.05%
2001-03-312001-04-25-$12.60-$16.2022.22%
2000-12-312001-03-01-$14.40-$13.50-6.67%
2000-09-302000-10-25-$12.60-$12.600%
2000-06-302000-06-30-$9.79
2000-03-312000-04-27-$7.20-$10.8033.33%
1996-12-311997-02-19-$16.20-$18.0010%
1996-09-301996-11-06-$18.00-$18.000%
1996-06-301996-07-23-$39.60-$18.00-120%
1995-12-311996-02-27-$28.80-$25.20-14.29%
1995-09-301995-11-10-$32.40-$27.00-20%
1995-06-301995-08-11-$27.00-$25.20-7.14%
1995-03-311995-05-12-$25.20-$23.40-7.69%
1994-12-311995-02-15-$19.80-$35.1043.59%
1994-09-301994-11-10-$23.40-$24.303.7%
1994-06-301994-08-02-$23.40-$25.207.14%
1994-03-311994-05-02-$19.80-$25.2021.43%
1993-09-301993-10-29-$27.00-$21.60-25%
1993-03-311993-05-12-$23.40-$18.00-30%

Celldex Therapeutics, Inc (CLDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Celldex Therapeutics, Inc (CLDX) Chart:

CLDX chart by TradingView

Celldex Therapeutics, Inc (CLDX) News:

Below you will find a list of latest news for Celldex Therapeutics, Inc (CLDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Celldex Therapeutics, Inc (CLDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-17100CALL0 0121.12TRUE00
2025-04-17110CALL0 092.07TRUE00
2025-04-17120CALL0 056.76TRUE00
2025-04-17130CALL0 0158.82TRUE00
2025-04-17140CALL0 0178.9TRUE00
2025-04-17150CALL0 0239.79TRUE00
2025-04-17160CALL0 0207.46FALSE00
2025-04-17170CALL0 0201.43FALSE00
2025-04-17183.1CALL0 11353FALSE00
2025-04-17190CALL0 0386.28FALSE00
2025-04-17200CALL0 0410.36FALSE00
2025-04-17212.05CALL0 20168.63FALSE00
2025-04-17220.5CALL0 15473.58FALSE00
2025-04-17230.54CALL0 5496.44FALSE00
2025-04-17241.13CALL0 11517.67FALSE00
2025-04-17251.65CALL0 1537.5FALSE00
2025-04-17260CALL0 0556.09FALSE00
2025-04-17270CALL0 0573.59FALSE00
2025-04-17280CALL0 0590.13FALSE00
2025-04-17290CALL0 0605.79FALSE00
2025-04-17300CALL0 0620.67FALSE00
2025-04-17350CALL0 0685.55FALSE00
2025-04-17100PUT0 0709.53FALSE00
2025-04-17110PUT0 0622.78FALSE00
2025-04-17120PUT0 0544.14FALSE00
2025-04-17130PUT0 0471.43FALSE00
2025-04-17140PUT0 0250.12FALSE00
2025-04-17150PUT0 0212.8FALSE00
2025-04-17160PUT0 0265.19TRUE00
2025-04-17171.75PUT0 1204.61TRUE00
2025-04-17180.4PUT0 10142.7TRUE00
2025-04-17191.45PUT0 189.2TRUE00
2025-04-17202.13PUT0 21370.7TRUE00
2025-04-17210PUT0 0420.68TRUE00
2025-04-17222.68PUT0 0480TRUE00
2025-04-17230PUT0 0420.77TRUE00
2025-04-17240PUT0 0209.88TRUE00
2025-04-17250PUT0 0544.22TRUE00
2025-04-17260PUT0 0503.59TRUE00
2025-04-17270PUT0 0251.91TRUE00
2025-04-17280PUT0 0264.47TRUE00
2025-04-17290PUT0 0276.43TRUE00
2025-04-17300PUT0 0627.87TRUE00
2025-04-17350PUT0 0693.2TRUE00
2025-05-16100CALL0 0123.99TRUE00
2025-05-16110CALL0 0109.34TRUE00
2025-05-1612.50CALL0 0116.29TRUE00
2025-05-16140CALL0 095.24TRUE00
2025-05-16152.58CALL0 1093.62TRUE00
2025-05-16160CALL0 0121.99FALSE00
2025-05-1617.58CALL0 1151.6FALSE00
2025-05-16190.8CALL403 1689.15FALSE0.80
2025-05-16200.85CALL0 4177.56FALSE00
2025-05-16210.95CALL0 267186.95FALSE00
2025-05-1622.51.09CALL0 25195.26FALSE00
2025-05-16240.75CALL0 53168.9FALSE00
2025-05-16250.52CALL0 44110.78FALSE00
2025-05-16260.65CALL0 1244.5FALSE00
2025-05-16270.5CALL0 1252.23FALSE00
2025-05-16283.54CALL0 178259.53FALSE00
2025-05-16290.3CALL0 11266.45FALSE00
2025-05-16300.75CALL0 116273.02FALSE00
2025-05-16310CALL0 0279.28FALSE00
2025-05-16320CALL0 0285.25FALSE00
2025-05-16330CALL0 0290.96FALSE00
2025-05-16340CALL0 0164.21FALSE00
2025-05-16350.2CALL0 339301.67FALSE00
2025-05-16360CALL0 0306.71FALSE00
2025-05-16370CALL0 0311.56FALSE00
2025-05-16380CALL0 0316.24FALSE00
2025-05-16390CALL0 0320.74FALSE00
2025-05-16400.1CALL0 147172.67FALSE00
2025-05-16450.05CALL0 37344.85FALSE00
2025-05-16500.5CALL0 46361.91FALSE00
2025-05-16551.25CALL0 2376.88FALSE00
2025-05-16600CALL0 0367.32FALSE00
2025-05-16650CALL0 0186.19FALSE00
2025-05-16100PUT0 0310.11FALSE00
2025-05-16110PUT0 0272.2FALSE00
2025-05-1612.50PUT0 0224.86FALSE00
2025-05-16140.35PUT0 1187.51FALSE00
2025-05-16151.03PUT0 2153.83FALSE00
2025-05-16160PUT0 0120.88TRUE00
2025-05-1617.51.35PUT0 891.67TRUE00
2025-05-16192.43PUT0 186.8TRUE00
2025-05-16202.05PUT0 2183.23TRUE00
2025-05-16210PUT0 074.03TRUE00
2025-05-1622.53.7PUT0 5995.48TRUE00
2025-05-16240PUT0 097.61TRUE00
2025-05-16254.6PUT0 56104.5TRUE00
2025-05-16260PUT0 0111.01TRUE00
2025-05-16274.87PUT0 178122.56TRUE00
2025-05-16280PUT0 0266.67TRUE00
2025-05-16290PUT0 0273.76TRUE00
2025-05-16309.3PUT0 548133.95TRUE00
2025-05-16310PUT0 0139.07TRUE00
2025-05-16320PUT0 0143.97TRUE00
2025-05-16330PUT0 0272.14TRUE00
2025-05-16340PUT0 0288.59TRUE00
2025-05-16350PUT0 0293.95TRUE00
2025-05-16360PUT0 0288.14TRUE00
2025-05-16370PUT0 0293.08TRUE00
2025-05-16380PUT0 0297.84TRUE00
2025-05-16390PUT0 0302.44TRUE00
2025-05-164013.3PUT0 0306.89TRUE00
2025-05-16450PUT0 0327.15TRUE00
2025-05-16500PUT0 0372.58TRUE00
2025-05-16550PUT0 0388.31TRUE00
2025-05-16600PUT0 0402.39TRUE00
2025-05-16650PUT0 0415.12TRUE00
2025-08-1580CALL0 084.17TRUE00
2025-08-15100CALL0 0100.98TRUE00
2025-08-15110CALL0 0103.3TRUE00
2025-08-15120CALL0 084.37TRUE00
2025-08-15130CALL0 087.66TRUE00
2025-08-15140CALL0 088.54TRUE00
2025-08-15154.22CALL0 2586.3TRUE00
2025-08-15160CALL0 085.64FALSE00
2025-08-1517.510.2CALL0 184.4FALSE00
2025-08-15192.6CALL0 3086.03FALSE00
2025-08-15204.9CALL0 4199.14FALSE00
2025-08-15211.7CALL0 10194.12FALSE00
2025-08-1522.51.5CALL0 15094.37FALSE00
2025-08-15241.3CALL0 274.55FALSE00
2025-08-15251.2CALL0 10122.55FALSE00
2025-08-15261.1CALL0 2125.56FALSE00
2025-08-15273.6CALL0 4131.07FALSE00
2025-08-15281.9CALL0 10133.58FALSE00
2025-08-15292.5CALL0 13110.06FALSE00
2025-08-15301.3CALL0 2092.71FALSE00
2025-08-15311.05CALL0 11143.4FALSE00
2025-08-15320.74CALL0 1146.58FALSE00
2025-08-15332.1CALL0 0151.04FALSE00
2025-08-15342CALL0 2153.96FALSE00
2025-08-15351.8CALL0 7156.75FALSE00
2025-08-15360CALL0 0159.44FALSE00
2025-08-15372.3CALL0 1160.58FALSE00
2025-08-15380CALL0 0164.51FALSE00
2025-08-15390CALL0 1168.36FALSE00
2025-08-15401CALL0 1172.12FALSE00
2025-08-1580PUT0 0218.83FALSE00
2025-08-15100PUT0 0169.23FALSE00
2025-08-15110PUT0 0146.87FALSE00
2025-08-15120PUT0 0135.73FALSE00
2025-08-15130PUT0 0117.44FALSE00
2025-08-15141.05PUT0 5101.87FALSE00
2025-08-15152.48PUT0 2486.15FALSE00
2025-08-15161.7PUT0 684.4TRUE00
2025-08-1517.53PUT0 1580.21TRUE00
2025-08-15192.1PUT0 177.45TRUE00
2025-08-15204.1PUT0 684.71TRUE00
2025-08-15213.9PUT0 475.83TRUE00
2025-08-1522.58.1PUT0 382.94TRUE00
2025-08-15248PUT0 177.8TRUE00
2025-08-152510.7PUT0 38078.81TRUE00
2025-08-15260PUT0 086.55TRUE00
2025-08-15270PUT0 069.49TRUE00
2025-08-15280PUT0 072.94TRUE00
2025-08-15296.6PUT0 176.24TRUE00
2025-08-15307.3PUT0 179.4TRUE00
2025-08-15310PUT0 082.42TRUE00
2025-08-15320PUT0 085.33TRUE00
2025-08-15330PUT0 084.87TRUE00
2025-08-15340PUT0 0151.22TRUE00
2025-08-15350PUT0 093.43TRUE00
2025-08-15360PUT0 095.96TRUE00
2025-08-15370PUT0 0162.89TRUE00
2025-08-15380PUT0 093.38TRUE00
2025-08-15390PUT0 0182.54TRUE00
2025-08-15400PUT0 0170.76TRUE00
2025-11-2180CALL0 092.09TRUE00
2025-11-21100CALL0 084.18TRUE00
2025-11-21110CALL0 084.71TRUE00
2025-11-21120CALL0 089.2TRUE00
2025-11-21130CALL0 076.61TRUE00
2025-11-21140CALL0 076.48TRUE00
2025-11-21150CALL0 075.35TRUE00
2025-11-21160CALL0 073.41FALSE00
2025-11-21170CALL0 076.93FALSE00
2025-11-21180CALL0 076.54FALSE00
2025-11-21190CALL0 095.69FALSE00
2025-11-21200CALL0 094.97FALSE00
2025-11-21213.3CALL0 270.7FALSE00
2025-11-21223CALL0 273.08FALSE00
2025-11-21232.9CALL0 183.3FALSE00
2025-11-21242.7CALL0 381.94FALSE00
2025-11-21252.45CALL0 189.61FALSE00
2025-11-21260CALL0 084.5FALSE00
2025-11-21271.85CALL0 184.3FALSE00
2025-11-21280CALL0 087.17FALSE00
2025-11-21300CALL0 0104.41FALSE00
2025-11-21350CALL0 0115.93FALSE00
2025-11-2180.4PUT0 1165.99FALSE00
2025-11-21100PUT0 0127.81FALSE00
2025-11-21110PUT0 0115.49FALSE00
2025-11-21121.9PUT0 192.59FALSE00
2025-11-21132.35PUT0 187.83FALSE00
2025-11-21140PUT0 078.03FALSE00
2025-11-21150PUT0 077.22FALSE00
2025-11-21164.2PUT0 174.51TRUE00
2025-11-21172.6PUT0 193.94TRUE00
2025-11-21183.1PUT0 198.7TRUE00
2025-11-21190PUT0 0100.77TRUE00
2025-11-21204.1PUT0 196.26TRUE00
2025-11-21210PUT0 076.19TRUE00
2025-11-21220PUT0 098.16TRUE00
2025-11-21230PUT0 080.11TRUE00
2025-11-21240PUT0 073.35TRUE00
2025-11-21250PUT0 077.06TRUE00
2025-11-21260PUT0 075.93TRUE00
2025-11-21270PUT0 071.66TRUE00
2025-11-21280PUT0 075.98TRUE00
2025-11-21300PUT0 080.3TRUE00
2025-11-21350PUT0 089.57TRUE00
2025-12-1950CALL0 092.24TRUE00
2025-12-1980CALL0 083.56TRUE00
2025-12-19100CALL0 076.99TRUE00
2025-12-1912.56.35CALL0 1680.05TRUE00
2025-12-19154.5CALL0 384.29TRUE00
2025-12-1917.54.41CALL0 1964.9FALSE00
2025-12-19202.8CALL0 1670.81FALSE00
2025-12-1922.52.64CALL0 2171.08FALSE00
2025-12-19251.9CALL0 3363.9FALSE00
2025-12-19271.65CALL0 787.36FALSE00
2025-12-19302CALL0 31984.85FALSE00
2025-12-19321.7CALL0 20087.17FALSE00
2025-12-19350.63CALL0 23112.13FALSE00
2025-12-19370CALL0 0105.57FALSE00
2025-12-19401.91CALL0 12122.06FALSE00
2025-12-19452.02CALL0 31110.15FALSE00
2025-12-19501.55CALL0 41131.91FALSE00
2025-12-19551.25CALL0 7143.84FALSE00
2025-12-19601.05CALL0 15145.8FALSE00
2025-12-19650.8CALL0 28150.35FALSE00
2025-12-1950PUT0 0245.27FALSE00
2025-12-1980PUT0 0156.98FALSE00
2025-12-19100PUT0 0117.09FALSE00
2025-12-1912.51.5PUT0 1374.39FALSE00
2025-12-19152PUT0 1078.49FALSE00
2025-12-1917.52.5PUT0 2379.27TRUE00
2025-12-19206.4PUT0 277.15TRUE00
2025-12-1922.58.2PUT0 174.26TRUE00
2025-12-19258.57PUT0 573.53TRUE00
2025-12-19270PUT0 068.55TRUE00
2025-12-193016.1PUT0 93775.52TRUE00
2025-12-19320PUT0 074.82TRUE00
2025-12-19350PUT0 081.37TRUE00
2025-12-19370PUT0 076.47TRUE00
2025-12-194013.2PUT0 581.8TRUE00
2025-12-19450PUT0 084.69TRUE00
2025-12-19500PUT0 0153.91TRUE00
2025-12-19550PUT0 0150.53TRUE00
2025-12-19600PUT0 0156.86TRUE00
2025-12-19650PUT0 0162.66TRUE00

Latest CLDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST2$20.54
Jun 13, 2022 7:59 PM EST61$20.52
Jun 13, 2022 7:59 PM EST28$20.52
Jun 13, 2022 7:59 PM EST1$20.51
Jun 13, 2022 7:59 PM EST190$20.54

Celldex Therapeutics, Inc (CLDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000003877718000054/0000038777-18-000054-index.htm
2018-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000021545718005851/0000215457-18-005851-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001108/0000315066-18-001108-index.htm
2018-05-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000031506618001910/0000315066-18-001910-index.htm
2020-07-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000090266420002780/0000902664-20-002780-index.htm
2020-06-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000092189520001867/0000921895-20-001867-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247118003136/0000932471-18-003136-index.htm
2019-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093247119004430/0000932471-19-004430-index.htm
2020-10-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000093583620000571/0000935836-20-000571-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000103738920000083/0001037389-20-000083-index.htm
2018-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746918001363/0001047469-18-001363-index.htm
2018-04-19PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918002964/0001047469-18-002964-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746918003326/0001047469-18-003326-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746919000992/0001047469-19-000992-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746919002607/0001047469-19-002607-index.htm
2019-12-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000104746919006714/0001047469-19-006714-index.htm
2020-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/744218/000104746920001809/0001047469-20-001809-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/744218/000104746920002644/0001047469-20-002644-index.htm
2020-06-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003564/0001047469-20-003564-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003601/0001047469-20-003601-index.htm
2020-06-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003602/0001047469-20-003602-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000104746920003646/0001047469-20-003646-index.htm
2018-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918026170/0001104659-18-026170-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918031972/0001104659-18-031972-index.htm
2018-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918037447/0001104659-18-037447-index.htm
2018-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918040165/0001104659-18-040165-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918050496/0001104659-18-050496-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465918066648/0001104659-18-066648-index.htm
2018-11-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918070024/0001104659-18-070024-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465918072097/0001104659-18-072097-index.htm
2019-02-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919006667/0001104659-19-006667-index.htm
2019-05-07DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/744218/000110465919027504/0001104659-19-027504-index.htm
2019-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919027513/0001104659-19-027513-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919036671/0001104659-19-036671-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919036997/0001104659-19-036997-index.htm
2019-06-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465919037010/0001104659-19-037010-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465919037195/0001104659-19-037195-index.htm
2019-07-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000110465919039565/0001104659-19-039565-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919044531/0001104659-19-044531-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465919062181/0001104659-19-062181-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/744218/000110465920039253/0001104659-20-039253-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920057436/0001104659-20-057436-index.htm
2020-06-12S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/744218/000110465920072503/0001104659-20-072503-index.htm
2020-06-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/744218/000110465920072779/0001104659-20-072779-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920072934/0001104659-20-072934-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073386/0001104659-20-073386-index.htm
2020-06-15S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/744218/000110465920073505/0001104659-20-073505-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920073843/0001104659-20-073843-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920074646/0001104659-20-074646-index.htm
2020-06-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/744218/000110465920077437/0001104659-20-077437-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920091459/0001104659-20-091459-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920096505/0001104659-20-096505-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/744218/000110465920121786/0001104659-20-121786-index.htm
2020-11-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/744218/000110465920122483/0001104659-20-122483-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000110465920122521/0001104659-20-122521-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318001754/0001171843-18-001754-index.htm
2018-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318002723/0001171843-18-002723-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318003787/0001171843-18-003787-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318005867/0001171843-18-005867-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184318007706/0001171843-18-007706-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319001578/0001171843-19-001578-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319003062/0001171843-19-003062-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319005251/0001171843-19-005251-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184319007429/0001171843-19-007429-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320002037/0001171843-20-002037-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320003372/0001171843-20-003372-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320005651/0001171843-20-005651-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/744218/000117184320007664/0001171843-20-007664-index.htm
2018-03-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018003192/0001179110-18-003192-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018005108/0001179110-18-005108-index.htm
2018-05-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018006035/0001179110-18-006035-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018007858/0001179110-18-007858-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008556/0001179110-18-008556-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008557/0001179110-18-008557-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008558/0001179110-18-008558-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008559/0001179110-18-008559-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008560/0001179110-18-008560-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008561/0001179110-18-008561-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008562/0001179110-18-008562-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008563/0001179110-18-008563-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008564/0001179110-18-008564-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008565/0001179110-18-008565-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008566/0001179110-18-008566-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008567/0001179110-18-008567-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008568/0001179110-18-008568-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008569/0001179110-18-008569-index.htm
2018-06-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008570/0001179110-18-008570-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018009240/0001179110-18-009240-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010087/0001179110-18-010087-index.htm
2018-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2018-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018011797/0001179110-18-011797-index.htm
2018-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018012450/0001179110-18-012450-index.htm
2018-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911018013378/0001179110-18-013378-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007967/0001179110-19-007967-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007968/0001179110-19-007968-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007969/0001179110-19-007969-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007970/0001179110-19-007970-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007971/0001179110-19-007971-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007972/0001179110-19-007972-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007973/0001179110-19-007973-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007974/0001179110-19-007974-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007975/0001179110-19-007975-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007976/0001179110-19-007976-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007977/0001179110-19-007977-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007978/0001179110-19-007978-index.htm
2019-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019007979/0001179110-19-007979-index.htm
2019-07-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911019008540/0001179110-19-008540-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007585/0001179110-20-007585-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007586/0001179110-20-007586-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007587/0001179110-20-007587-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007588/0001179110-20-007588-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007589/0001179110-20-007589-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007590/0001179110-20-007590-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007591/0001179110-20-007591-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007592/0001179110-20-007592-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007593/0001179110-20-007593-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007594/0001179110-20-007594-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007595/0001179110-20-007595-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007596/0001179110-20-007596-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007597/0001179110-20-007597-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000117911020007598/0001179110-20-007598-index.htm
2018-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/744218/000118248918000319/0001182489-18-000319-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312518041541/0001193125-18-041541-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312519039738/0001193125-19-039738-index.htm
2020-06-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000119312520171962/0001193125-20-171962-index.htm
2020-06-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/744218/000149315220011453/0001493152-20-011453-index.htm
2020-06-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/744218/999999999520001412/9999999995-20-001412-index.htm
2018-04-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/744218/999999999718005092/9999999997-18-005092-index.htm

Celldex Therapeutics, Inc (CLDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Celldex Therapeutics, Inc (CLDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 16%
Institutional Ownership: 8207%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-06-09Margo Heath-ChiozziSVP of Regulatory AffairsBuy1,000.003.013,005.001,000.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007167/0001179110-20-007167-index.htm
2020-06-09Samuel Bates MartinSVP and CFOBuy9,750.003.0529,737.5010,735.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007166/0001179110-20-007166-index.htm
2020-06-09JAMES J MARINODirectorBuy8,305.003.0024,915.0012,704.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007165/0001179110-20-007165-index.htm
2020-06-10Sarah CavanaughSVP of Corp Affairs & Admin.Buy1,050.004.835,071.501,367.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007218/0001179110-20-007218-index.htm
2020-06-09Anthony S MarucciPresident & CEOBuy15,000.003.0645,900.0019,438.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007163/0001179110-20-007163-index.htm
2020-06-11Diane C. YoungSVP, Chief Medical OfficerBuy2,115.004.7310,003.952,115.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007242/0001179110-20-007242-index.htm
2018-06-15TIBOR KELERExecutive VP & CSOBuy16,500.000.599,782.8535,368.00https://www.sec.gov/Archives/edgar/data/744218/000117911018008669/0001179110-18-008669-index.htm
2018-08-24JAMES J MARINODirectorBuy40,000.000.4819,200.0065,997.00https://www.sec.gov/Archives/edgar/data/744218/000117911018010938/0001179110-18-010938-index.htm
2020-06-09TIBOR KELERExecutive VP & CSOBuy5,000.002.9914,954.007,357.00https://www.sec.gov/Archives/edgar/data/744218/000117911020007164/0001179110-20-007164-index.htm